Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia

Clinical trial NCT01804101 · COMPLETED

Trial details

NCT number: NCT01804101
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Biphenotypic Leukemia Acute Myeloid Leukemia Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia

Start date: 2013-05-07
Primary completion: 2017-01-10
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.